These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 16277756)
1. Virus-host interactions: new insights from the small RNA world. Browne EP; Li J; Chong M; Littman DR Genome Biol; 2005; 6(11):238. PubMed ID: 16277756 [TBL] [Abstract][Full Text] [Related]
2. HIV-l and the microRNA-guided silencing pathway: an intricate and multifaceted encounter. Provost P; Barat C; Plante I; Tremblay MJ Virus Res; 2006 Nov; 121(2):107-15. PubMed ID: 16889864 [TBL] [Abstract][Full Text] [Related]
3. Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Bennasser Y; Le SY; Benkirane M; Jeang KT Immunity; 2005 May; 22(5):607-19. PubMed ID: 15894278 [TBL] [Abstract][Full Text] [Related]
4. The silent treatment: RNAi as a defense against virus infection in mammals. van Rij RP; Andino R Trends Biotechnol; 2006 Apr; 24(4):186-93. PubMed ID: 16503061 [TBL] [Abstract][Full Text] [Related]
5. Induction and suppression of RNA silencing: insights from viral infections. Voinnet O Nat Rev Genet; 2005 Mar; 6(3):206-20. PubMed ID: 15703763 [TBL] [Abstract][Full Text] [Related]
6. RNA silencing as a cellular defense against HIV-1 infection: progress and issues. Sanghvi VR; Steel LF FASEB J; 2012 Oct; 26(10):3937-45. PubMed ID: 22751007 [TBL] [Abstract][Full Text] [Related]
7. The Ebola virus VP35 protein is a suppressor of RNA silencing. Haasnoot J; de Vries W; Geutjes EJ; Prins M; de Haan P; Berkhout B PLoS Pathog; 2007 Jun; 3(6):e86. PubMed ID: 17590081 [TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat interaction with Dicer: requirement for RNA. Bennasser Y; Jeang KT Retrovirology; 2006 Dec; 3():95. PubMed ID: 17181864 [TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 escape from RNA interference. Boden D; Pusch O; Lee F; Tucker L; Ramratnam B J Virol; 2003 Nov; 77(21):11531-5. PubMed ID: 14557638 [TBL] [Abstract][Full Text] [Related]
10. [Micro RNA and viral infections in mammals]. Pfeffer S J Soc Biol; 2007; 201(4):377-84. PubMed ID: 18533098 [TBL] [Abstract][Full Text] [Related]
11. Peptide models of the Tat-TAR protein-RNA interaction. Frankel AD Protein Sci; 1992 Dec; 1(12):1539-42. PubMed ID: 1304886 [No Abstract] [Full Text] [Related]
12. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Triboulet R; Mari B; Lin YL; Chable-Bessia C; Bennasser Y; Lebrigand K; Cardinaud B; Maurin T; Barbry P; Baillat V; Reynes J; Corbeau P; Jeang KT; Benkirane M Science; 2007 Mar; 315(5818):1579-82. PubMed ID: 17322031 [TBL] [Abstract][Full Text] [Related]
13. The HIV-1 Tat transactivator protein: a therapeutic target? Fulcher AJ; Jans DA IUBMB Life; 2003 Dec; 55(12):669-80. PubMed ID: 14769003 [TBL] [Abstract][Full Text] [Related]
14. Micro-RNA: new players in HIV-pathogenesis, diagnosis, prognosis and antiviral therapy. Fowler L; Saksena NK AIDS Rev; 2013; 15(1):3-14. PubMed ID: 23449224 [TBL] [Abstract][Full Text] [Related]
15. Fragments of the HIV-Tat protein specifically bind TAR RNA. Dis Markers; 1991; 9(1):58-9. PubMed ID: 1742953 [No Abstract] [Full Text] [Related]
16. Biochemical and functional interactions between HIV-1 Tat protein and TAR RNA. Rana TM; Jeang KT Arch Biochem Biophys; 1999 May; 365(2):175-85. PubMed ID: 10328810 [TBL] [Abstract][Full Text] [Related]
17. Generation of nuclease resistant circular RNA decoys for HIV-Tat and HIV-Rev by autocatalytic splicing. Puttaraju M; Been MD Nucleic Acids Symp Ser; 1995; (33):152-5. PubMed ID: 8643355 [TBL] [Abstract][Full Text] [Related]
18. [RNA ligands for HIV proteins]. Iwai S Tanpakushitsu Kakusan Koso; 1995 Jul; 40(10):1430-7. PubMed ID: 7568944 [No Abstract] [Full Text] [Related]